General
Preferred name
TARIBAVIRIN
Synonyms
Viramidine ()
Taribavirin (hydrochloride) ()
Taribavirine ()
Taribavirina ()
Taribavirin hcl ()
TARIBAVIRIN HYDROCHLORIDE ()
P&D ID
PD073226
CAS
119567-79-2
40372-00-7
Tags
available
drug
prodrug
drug candidate
Drug indication
Hepatitis C virus infection
chronic hepatitis C virus infection
Drug Status
approved
investigational
Max Phase
3.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Taribavirin hydrochloride is an orally active inosine monophosphate dehydrogenase inhibitor, has activity against a wide range of viruses, especially the hepatitis C virus and influenza virus. Taribavirin hydrochloride is a Ribavirin proagent, is designed to concentrate within the liver to target HCV-infected hepatocytes while minimizing distribution within red blood cells (RBCs) and the development of hemolytic anemia[2].
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
6
ChEMBL Drugs
DrugBank
DrugCentral
DrugCentral Approved Drugs
DrugMAP
MedChem Express Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
45
Molecular Weight
243.1
Hydrogen Bond Acceptors
8
Hydrogen Bond Donors
5
Rotatable Bonds
3
Ring Count
2
Aromatic Ring Count
1
cLogP
-2.83
TPSA
150.5
Fraction CSP3
0.62
Chiral centers
4.0
Largest ring
5.0
QED
0.28
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
Anti-infection
Target
HBV
HCV
Source data

